[1]
|
Jahromi, B.N., Borzou, N., Parsanezhad, M.E., et al. (2021) Associations of Insulin Resistance, Sex Hormone-Binding Globulin, Triglyceride, and Hormonal Profiles in Polycystic Ovary Syndrome: A Cross-Sectional Study. International Journal of Reproductive Biomedicine, 19, 653-662.
|
[2]
|
Harris, H.R., Titus, L.J., Cramer, D.W., et al. (2017) Long and Irregular Menstrual Cycles, Polycystic Ovary Syndrome, and Ovarian Cancer Risk in a Population-Based Case-Control Study. International Journal of Cancer, 140, 285-291.
https://doi.org/10.1002/ijc.30441
|
[3]
|
Abraham Gnanadass, S., Divakar Prabhu, Y. and Valsala Gopalakrishnan, A. (2021) Association of Metabolic and Inflammatory Markers with Polycystic Ovarian Syndrome (PCOS): An Update. Archives of Gynecology and Obstetrics, 303, 631-643. https://doi.org/10.1007/s00404-020-05951-2
|
[4]
|
Ding, H., Zhang, J., Zhang, F., et al. (2021) Resistance to the Insulin and Elevated Level of Androgen: A Major Cause of Polycys-tic Ovary Syndrome. Frontiers in Endocrinology, 12, Article 741764.
https://doi.org/10.3389/fendo.2021.741764
|
[5]
|
Wang, Y.X., Shan, Z., Arvizu, M., et al. (2020) Associations of Menstrual Cycle Characteristics across the Reproductive Life Span and Lifestyle Factors with Risk of Type 2 Diabetes. JAMA Network Open, 3, e2027928.
https://doi.org/10.1001/jamanetworkopen.2020.27928
|
[6]
|
Hussein, K. and Karami, M. (2023) Association be-tween Insulin Resistance and Abnormal Menstrual Cycle in Saudi Females with Polycystic Ovary Syndrome. Saudi Pharmaceutical Journal, 31, 1104-1108.
https://doi.org/10.1016/j.jsps.2023.03.021
|
[7]
|
Niu, J., Lu, M. and Liu, B. (2023) Association between Insulin Re-sistance and Abnormal Menstrual Cycle in Chinese Patients with Polycystic Ovary Syndrome. Journal of Ovarian Re-search, 16, Article No. 45.
https://doi.org/10.1186/s13048-023-01122-4
|
[8]
|
Li, X., Yang, D., Pan, P., et al. (2022) The Degree of Menstrual Disturbance Is Associated with the Severity of Insulin Resistance in PCOS. Frontiers in Endocrinology, 13, Article 873726. https://doi.org/10.3389/fendo.2022.873726
|
[9]
|
Li, X., Zhu, Q., Wang, W., et al. (2019) Elevated Chemerin Induces Insulin Resistance in Human Granulosa-Lutein Cells from Polycystic Ovary Syndrome Patients. FASEB Journal, 33, 11303-11313.
https://doi.org/10.1096/fj.201802829R
|
[10]
|
Zhang, C., Hu, J., Wang, W., et al. (2020) HMGB1-Induced Aberrant Autophagy Contributes to Insulin Resistance in Granulosa Cells in PCOS. FASEB Journal, 34, 9563-9574. https://doi.org/10.1096/fj.202000605RR
|
[11]
|
Stener-Victorin, E. and Deng, Q. (2021) Epigenetic Inheritance of Polycystic Ovary Syndrome—Challenges and Opportunities for Treatment. Nature Reviews Endocrinology, 17, 521-533. https://doi.org/10.1038/s41574-021-00517-x
|
[12]
|
Kamrul-Hasan, A., Aalpona, F.T.Z. and Selim, S. (2021) Clinical, Metabolic and Hormonal Profiles of Bangladeshi Adolescents with Polycystic Ovary Syndrome. Touch Reviews in En-docrinology, 17, 54-58.
https://doi.org/10.17925/EE.2021.17.1.54
|
[13]
|
Ezeh, U., Ezeh, C., Pisarska, M.D., et al. (2021) Menstrual Dys-function in Polycystic Ovary Syndrome: Association with Dynamic State Insulin Resistance Rather than Hyperandro-genism. Fertility and Sterility, 115, 1557-1568.
https://doi.org/10.1016/j.fertnstert.2020.12.015
|
[14]
|
Ezeh, U., Pisarska, M.D. and AndAzziz, R. (2022) Associa-tion of Severity of Menstrual Dysfunction with Hyperinsulinemia and Dysglycemia in Polycystic Ovary Syndrome. Human Reproduction, 37, 553-564.
https://doi.org/10.1093/humrep/deac001
|
[15]
|
Liao, B., Qi, X., Yun, C., et al. (2022) Effects of Androgen Ex-cess-Related Metabolic Disturbances on Granulosa Cell Function and Follicular Development. Frontiers in Endocrinolo-gy, 13, Article 815968.
https://doi.org/10.3389/fendo.2022.815968
|
[16]
|
Van Gerwen, J., Shun-Shion, A.S. and Fazakerley, D.J. (2023) Insulin Signalling and GLUT4 Trafficking in Insulin Resistance. Biochemical Society Transactions, 51, 1057-1069. https://doi.org/10.1042/BST20221066
|
[17]
|
Xiang, S., Xia, M.F., Song, J. Y., et al. (2021) Effect of Elec-tro-Acupuncture on Expression of IRS-1/PI3K/GLUT4 Pathway in Ovarian Granulosa Cells of Infertile Patients with Polycystic Ovary Syndrome-Insulin Resistance of Phlegm-Dampness Syndrome. Chinese Journal of Integrative Medi-cine, 27, 330-335.
https://doi.org/10.1007/s11655-020-3219-z
|
[18]
|
Zhang, H., Wang, W., Zhao, J., et al. (2023) Relationship between Body Composition, Insulin Resistance, and Hormonal Profiles in Women with Polycystic Ovary Syndrome. Frontiers in Endocrinology, 13, Article 1085656.
https://doi.org/10.3389/fendo.2022.1085656
|
[19]
|
Huang, X., Wang, Q., Liu, T., et al. (2019) Body Fat Indices as Effective Predictors of Insulin Resistance in Obese/Non-Obese Polycystic Ovary Syndrome Women in the Southwest of China. Endocrine, 65, 81-85.
https://doi.org/10.1007/s12020-019-01912-1
|
[20]
|
Erensoy, H., Niafar, M., Ghafarzadeh, S., et al. (2019) A Pilot Trial of Metformin for Insulin Resistance and Mood Disturbances in Adolescent and Adult Women with Polycystic Ovary Syndrome. Gynecological Endocrinology, 35, 72-75. https://doi.org/10.1080/09513590.2018.1498476
|
[21]
|
Oztas, E., Ozler, S., Tokmak, A., et al. (2016) Increased Levels of Serum Granzyme-B Is Associated with Insulin Resistance and Increased Cardiovascular Risk in Adolescent Polycystic Ovary Syndrome Patients. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 198, 89-93. https://doi.org/10.1016/j.ejogrb.2016.01.009
|
[22]
|
Brower, M., Brennan, K., Pall, M., et al. (2013) The Se-verity of Menstrual Dysfunction as a Predictor of Insulin Resistance in PCOS. The Journal of Clinical Endocrinology and Metabolism, 98, E1967-E1971.
https://doi.org/10.1210/jc.2013-2815
|
[23]
|
Thong, E.P., Codner, E., Laven, J.S.E., et al. (2020) Diabetes: A Meta-bolic and Reproductive Disorder in Women. The Lancet Diabetes & Endocrinology, 8, 134-149. https://doi.org/10.1016/S2213-8587(19)30345-6
|
[24]
|
Jagannathan, R., Neves, J.S., Dorcely, B., et al. (2020) The Oral Glucose Tolerance Test: 100 Years Later. Diabetes, Metabolic Syndrome and Obesity, 13, 3787-3805. https://doi.org/10.2147/DMSO.S246062
|